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Basophils and mast cells play important roles in host defense against parasitic infections and allergic
responses. Several progenitor populations, either shared or speciﬁc, for basophils and/or mast cells have
been identiﬁed, thus elucidating the developmental pathways of these cells. Multiple transcription
factors essential for their development and the relationships between them have been also revealed. For
example, IRF8 induces GATA2 expression to promote the generation of both basophils and mast cells. The
STAT5-GATA2 axis induces C/EBPa and MITF expression, facilitating the differentiation into basophils and
mast cells, respectively. In addition, C/EBPa and MITF mutually suppress each other's expression. This
review provides an overview of recent advances in our understanding of how transcription factors
regulate the development of basophils and mast cells.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).y, Yokohama City University
a-ku, Yokohama 236-0004,
mura).
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Basophils and mast cells are important effector cells that
contribute to host defense against parasitic infections and to
allergic responses.1e3 Basophils and mast cells express high-
afﬁnity immunoglobulin E (IgE) receptor (FcεRI) on their sur-
faces. Cross-linking of FcεRI by antigen stimulation causes the
release of inﬂammatory cytokines and chemical mediators.2,4vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. A model for the developmental pathways of basophils and mast cells. Basophils
and mast cells develop from HSCs via MPPs, CMPs, and GMPs. Bipotential progenitors
capable of differentiating into either basophils or mast cells include bone marrow pre-
BMPs and spleen BMCPs. These bipotential progenitors differentiate to unipotent
progenitors, BaPs and MCPs. MCPs differentiate into mast cells after migration to
tissue.
H. Sasaki et al. / Allergology International 65 (2016) 127e134128While basophils and mast cells have many similarities, they also
have distinct characteristics.3,5 Mast cells reside mainly in tis-
sues and are barely detected in blood. However, basophils
circulate in blood and migrate to tissues in response to stimuli.
In addition, mast cells have a life span of several weeks to
months, whereas basophils survive approximately 60 h. Nuclear
morphology and expression of several surface receptors also
differ between basophils and mast cells. Consequently, they
possess non-redundant functions, although these distinctions
are not described in detail here.
In recent years, basophil andmast cell development has been an
active area of research, resulting in the identiﬁcation of various
progenitors and transcription factors that regulate their develop-
ment. This review presents an outline of the mechanisms of
developmental regulation of basophils and mast cells, based on
currently available information.
Developmental pathways of basophils and mast cells
Basophils and mast cells develop from hematopoietic stem cells
(HSCs) via common myeloid progenitors (CMPs) and granulocyte-
monocyte progenitors (GMPs).6,7 In addition, granulocyte pro-
genitors (GPs),8,9 capable of differentiating into granulocytes
(neutrophils, eosinophils, and basophils) and mast cells; bone
marrow pre-basophil and mast cell progenitors (pre-BMPs),10
capable of differentiating into basophils and mast cells; spleen
basophil-mast cell progenitors (BMCPs),11 also capable of differ-
entiating into basophils and mast cells; basophil progenitors
(BaPs),11 which differentiate only into basophils; and mast cell
progenitors (MCPs),11,12 which differentiate only into mast cells
have been reported (Fig. 1).
GPs were originally identiﬁed as Sca-1 Lin c-Kitþ CD150
CD27þ integrin b7 (SN) cells and classiﬁed into two types, Flt3þ
GPs and Flt3 GPs, based on the expression level of FMS-like
tyrosine kinase 3 (FLT3).8,9 Both GP populations differentiate pri-
marily into granulocytes and possess some capability to give rise to
mast cells, but Flt3 GPs have higher potential to develop into
basophils and mast cells.9
Two types of bipotential progenitor populations, with the po-
tential to differentiate into either basophils or mast cells, have been
identiﬁed. One type is spleen BMCPs, discovered by Arinobu et al.,11
and the other is bone marrow pre-BMPs, reported by Qi et al.10
In vitro culture experiments have revealed that BMCPs produce
basophils via BaPs andmast cells via MCPs (Fig. 1).11 Pre-BMPs are a
subpopulation of GMPs with high FcεRIa expression, and trans-
plantation experiments have revealed that pre-BMPs have high
potential to develop into basophils and mast cells.10 Of note, pre-
BMPs have been demonstrated to have higher potential to
develop into basophils than BMCPs.10
BaPs are mainly present in the bone marrow, while MCPs are
present not only in the bone marrow and spleen but also in the
peripheral tissues, including the intestine.11e13 After migrating to a
tissue through the peripheral blood, MCPs eventually differentiate
into mast cells.3,14 BaPs and MCPs are believed to develop from the
bipotential progenitors (BMCPs or pre-BMPs). However, there are
reports showing thatMCPs can also develop directly from upstream
progenitors, such as CMPs or multipotent progenitors (MPPs).8,12
Because all of the abovementioned progenitor populations were
identiﬁed using distinct sets of surface markers (Table 1),8,10e13,15
the exact relationships among them are somewhat obscure.
Furthermore, as in the case of GMPs that include pre-BMPs,
whether or not individual progenitor populations are homoge-
neous awaits further investigation. Nevertheless, based on their
differentiation potential, it is reasonable to assume that GMPs
differentiate into GPs, which differentiate into bipotentialprogenitors (pre-BMPs or BMCPs) and then into unipotential pro-
genitors (BaPs or MCPs) to give rise to basophils and mast cells
(Fig. 1).
Expression of transcription factors important for basophil
and mast cell development
Cellular processes, such as cell differentiation, that involve
changes in gene expression patterns are regulated by various fac-
tors such as cytokines, micro-RNAs, epigenetic mechanisms, and
transcription factors. Especially, transcription factors that bind to
speciﬁc DNA sequences in the genome to directly regulate gene
expression are key determinants of cell fate.16 Indeed, multiple
Table 1
Surface markers on progenitors of the basophil and mast cell lineages.
Cell type Surface expression Reference
GMPs Lineage markers (CD3, CD4, CD8, B220, Gr-1, TER119, CD19, IgM), Sca-1, c-Kitþ, IL-7Ra, CD34þ, CD16/32hi 15
Flt3þ GPs Lineage markers (CD3, CD4, CD5, CD8, CD11b, B220, Gr-1, TER119), Sca-1, c-Kitþ, Ly6C, FcεRIa, CD71, CD41, CD27þ,
integrin b7, Flt3 (CD135)þ, CD150
8
Flt3 GPs Lineage markers (CD3, CD4, CD5, CD8, CD11b, B220, Gr-1, TER119), Sca-1, c-Kitþ, Ly6C, FcεRIa, CD71, CD41, CD27þ,
integrin b7, Flt3 (CD135), CD150
8
pre-BMPs Lineage markers (CD3, CD4, CD8, CD19, B220, Gr-1), Sca-1, c-Kitþ, FcεRIaþ, CD34þ, CD16/32hi 10
BMCPs Lineage markers (CD3, CD4, CD8, CD19, B220, Gr-1), c-Kitþ, integrin b7hi, CD16/32hi 11
BaPs Lineage markers (CD3, CD4, CD8, CD19, B220, Gr-1), c-Kit, FcεRIaþ, CD34þ 11
BM MCPs Lineage markers (CD3, CD4, CD5, CD8, CD11b, B220, Gr-1, TER119), Sca-1, c-Kitþ, Ly6C, FcεRIa, CD27, integrin b7þ, T1/ST2þ 12
SP MCPs Lineage markers (CD3, CD4, CD5, CD8, CD11b, B220, Gr-1, TER119), Sca-1, c-Kitþ, Ly6C, FcεRIa, CD27, integrin b7þ, T1/ST2þ 13
SI MCPs Lineage markers (CD3, CD4, CD8, CD19, B220, Gr-1), CD45þ, FcεRIalo, CD34þ, integrin b7þ 11
BM, bone marrow; SP, spleen; SI, small intestine.
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or mast cell development, including interferon regulatory factor-8
(IRF8), CCAAT/enhancer binding protein-a (C/EBPa), GATA-
binding protein-1 (GATA1), GATA2, IKAROS family zinc ﬁnger-1
(IKAROS/IKZF1), microphthalmia-associated transcription factor
(MITF), runt-related transcription factor 1 (RUNX1), and signal
transducer and activator of transcription-5 (STAT5).9e11,13,14,17e27
The expression of these transcription factors changes during
basophil and mast cell differentiation (summarized in Fig. 2A).
GMPs and GPs express Cebpa, Ikaros, Stat5, and Irf8.10,11,17,18 Upon
differentiation to pre-BMPs, Irf8 expression decreases, whereas the
expression of Cebpa, Stat5, and Gata2 increases.10,13,17,24 On the
other hand, with differentiation to BMCPs, not only Irf8 but also
Cebpa expression decreases, whereas the expression of Gata1,
Gata2, and Ikzf1 increases.11,13,18 BaPs and basophils show high
expression of Cebpa, but do not expressMitf.10,11,18 In sharp contrast,
mast cells show high expression ofMitf, but do not express Cebpa.10
It is unclear at which differentiation stage Runx1 is expressed.
Below, we will describe the role of each of these transcription
factors.
Developmental defects in basophil and mast cell lineages in
mice deﬁcient in STAT5, GATA2, C/EBPa, or MITF
We ﬁrst describe the phenotype of mice deﬁcient in STAT5,
GATA2, C/EBPa, or MITF (Fig. 2B).10,24e26,28e30 Basophil numbers
reconstituted with fetal liver cells from Stat5/ mice were mark-
edly lower than those reconstituted with wild-type cells.26 Condi-
tional Stat5 knockout mice in which the Stat5a/b locus is deleted in
a polyinosinicepolycytidylic acid (poly IeC)-inducible man-
ner,10,31e33 also showed a decrease by half in the numbers of pre-
BMPs, BaPs, and basophils, while the numbers of CMPs, GMPs,
and BMCPs are unchanged (Fig. 2B).10 In addition, tissue mast cells
were signiﬁcantly diminished in Stat5/ mice or Stat5/ bone
marrow chimeric mice.25 Therefore, STAT5, which is activated by
cytokines such as IL-3 and stem cell factor (SCF) that promote
basophil and mast cell development, is indispensable for the gen-
eration of both basophils and mast cells.5,10,24e26
Biallelic deletion of Gata2 results in a marked reduction in ba-
sophils and mast cells in vivo, whereas monoallelic deletion of
Gata2 causes a decrease only in mast cells.24 These results
demonstrate that GATA2, known as a key regulator of HSCs and
early progenitor cells, also contributes to the development of ba-
sophils and mast cells, although the need for GATA2 is greater for
mast cells.18,21,24
C/EBPa, known to be essential for the development of various
myeloid cells, is also required for basophil development.10,11,13,18
Arinobu et al., who performed a pioneering study on the mecha-
nisms of basophil and mast cell development, revealed thatconditional deletion of C/EBPa in BMCPs in vitro28 caused the loss of
potential for BMCPs to differentiate into basophils, and these cells
differentiated exclusively into mast cells.11 In addition, forced
expression of C/EBPa in BMCPs facilitates differentiation into ba-
sophils. Recently, the percentage of pre-BMPs has been shown to be
markedly lower in C/EBPa conditional knockoutmice.10 Conditional
deletion of C/EBPa in pre-BMPs also abolished their potential to
differentiate into basophils in vitro. Taken together, these results
indicate that C/EBPa is required for basophil-mast cell bipotential
progenitors to differentiate into basophils.10
In MITF-deﬁcient mice, the numbers of mast cell precursors and
mast cells are markedly lower than in wild-type mice, demon-
strating the essential role of MITF in mast cell development
(Fig. 2B).29,34,35
Relationships between STAT5, GATA2, C/EBPa, and MITF in
basophil and mast cell development
Qi et al. reported that STAT5 expressed in pre-BMPs facilitates
basophil and mast cell development by inducing C/EBPa and MITF
expression.10 Thus, Cebpa expression is decreased in residual pre-
BMPs in STAT5-deﬁcient mice. In addition, wild-type GMPs
cultured in the presence of IL-3 upregulate Mitf as their differen-
tiation to the mast cell lineage proceeds, but this induction of Mitf
expression does not occur in STAT5-deﬁcient GMPs.10 Interestingly,
STAT5 directly binds to the promoter region of Gata2, and forced
expression of GATA2 restores basophil and mast cell development
in STAT5-deﬁcient progenitor cells,24 suggesting the importance of
the STAT5-GATA2 axis. Because GATA2 is required for the expres-
sion of Cebpa and Mitf in basophils and mast cells, respectively,24
the STAT5-GATA2 transcription factor cascade may operate in
bipotential progenitors and downstream cell stages to support the
development of both basophils and mast cells (Fig. 3).10,24
Introduction of GATA2 into common lymphocyte progenitors
(CLPs), in which differentiation potential is naturally limited to
lymphocytes, causes transdifferentiation to basophils and mast
cells.18 In addition, if CLPs are transduced by GATA2 and then by C/
EBPa, differentiation is limited to basophils. Therefore, upregula-
tion of GATA2 is important for the development of both basophils
and mast cells, whereas upregulation of GATA2 followed by C/EBPa
is important for basophil development, suggesting the importance
of ordered expression of transcription factors.18
Moreover, Qi et al. clariﬁed the mutual suppression mecha-
nisms of C/EBPa and MITF.10 The loss of C/EBPa upregulates Mitf
expression in basophils, whereas the loss of MITF upregulates
Cebpa expression in mast cells.10 In addition, C/EBPa binds to the
Mitf promoter region in basophils to suppress Mitf transcription,
whereas MITF binds to the Cebpa promoter region in mast cells
to suppress Cebpa transcription (Fig. 3).10 Importantly, even
Fig. 2. Transcription factors regulating the development of basophils and mast cells. (A) A heat map representing relative changes in the expression levels of transcription factors in
the basophil and mast cell lineages. (B) Changes in the numbers of basophil and mast cell lineage cells in mice deﬁcient for the indicated transcription factor. BM, bone marrow; SP,
spleen; SI, small intestine. y DdblGATA mice: deletion of GATA-binding site in the GATA-1 promoter. z Intestinal mast cells were reduced in Ikzf1/ mice. x Stat5/ mice: deletion of
Stat5a and Stat5b ﬁrst coding exon (Reference 25).
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C/EBPa is conditionally deleted.10 Therefore, mutually exclusive
expression of C/EBPa and MITF determines a basophil versus mast
cell fate.
Regulation of C/EBPa expression and basophil development by
IKAROS
IKAROS, encoded by Ikzf1 and known to be particularly impor-
tant for the development of lymphocytes, negatively regulates
basophil development.13,36 In IKAROS-deﬁcient mice, the numbers
of bonemarrow BaPs and basophils are increased (Fig. 2B).13 In vitroculture experiments using IKAROS-deﬁcient bone marrow cells
further demonstrated markedly enhanced differentiation into ba-
sophils in the absence of IKAROS. Chromatin immunoprecipitation
(ChIP) and gene expression analyses revealed that IKAROS directly
binds to Cebpa and Hes1 loci, down- (Cebpa) or up- (Hes1) regu-
lating histone H3 lysine 4 trimethylation (a chromatin signature of
transcription initiation), and suppressing (Cebpa) or promoting
(Hes1) expression of these genes.13 Hes1 encodes the transcription
factor hairy and enhancer of split 1 (HES1) that has been shown to
promote mast cell development and inhibit Cebpa expression
in vitro,37 althoughmast cells in HES1 knockout mice have not been
analyzed. Thus, IKAROS acts in a cell-intrinsic way to inhibit
Fig. 3. A model for stage-speciﬁc regulation of basophil and mast cell development by transcription factors. IRF8, expressed in GMPs and GPs, induces GATA2 expression. When
differentiation proceeds from GMPs (possibly through GPs) to BMCPs, GATA2 expression is upregulated, while C/EBPa expression is downregulated. When differentiation proceeds
from GMPs (possibly through GPs) to pre-BMPs, the expression levels of STAT5, C/EBPa, and GATA2 are upregulated. BMCPs differentiate into BaPs upon upregulation of C/EBPa,
whereas BMCPs differentiate into MCPs if C/EBPa remains suppressed. In pre-BMPs and downstream cells, the STAT5-GATA2 axis appears to induce the expression of C/EBPa or
MITF. Induction of C/EBPa or MITF expression leads to the differentiation of these cells to BaPs or MCPs, respectively. C/EBPa and MITF mutually suppress each other's expression.
H. Sasaki et al. / Allergology International 65 (2016) 127e134 131basophil development, probably by suppressing C/EBPa expression
and promoting HES1 expression.13
Bone marrow MCPs and skin mast cells in IKAROS-deﬁcient
mice are as abundant as those in wild-type mice, and spleen
BMCPs and MCPs are more abundant, suggesting that IKAROS is
dispensable for the generation of these cells. Interestingly, how-
ever, the numbers of intestinal MCPs and mast cells are decreased
(Fig. 2B).13 This intestine-speciﬁc decrease is likely a result of the
downregulation of a4 integrin expression in IKAROS-deﬁcient
mice, because a4 integrin is required for homing of mast cells to
the intestine.38
Regulation of basophil and mast cell development by GATA1
GATA1 is known to be essential for the development of eryth-
rocytes, megakaryocytes, and eosinophils.39 Roles of GATA1 in
basophil and mast cell development have been studied using three
strains of mice21e23,39: mice in which both the enhancer and distal
promoter but not coding region of Gata1 are deleted (neoDHS
mice),40,41 mice in which exons of GATA1 are conditionally deleted
(Gata1/),42,43 and mice in which an enhancer with a high afﬁnity
double-GATA site but not coding region of Gata1 is excised
(DdblGATA).44 The effects onmast cells vary among these strains. In
neoDHS mice, MCP and mast cell development is impaired,22,45
whereas mast cells are present in the skin and stomach of
Gata1/mice in numbers comparable to those inwild-typemice.46
Although the number of mast cells in DdblGATA mice has not been
investigated, mast cell development can be induced from bone
marrow cells of these mice, similar to thewild type.44,46 GATA1wasknocked out in Gata1/ mice after birth, whereas neoDHS mice
had constitutively lower GATA1 expression from the embryonic
stage, which may be the reason for the distinctive phenotypes of
mast cell development. DdblGATA mice have been reported to
possess a smaller number of BaPs and basophils (Fig. 2B).23 The
number of basophils in neoDHS mice and Gata1/ mice has not
been investigated. Therefore, the induction of Gata1 gene expres-
sion by auto-activation is necessary for BaP and basophil develop-
ment in vivo, but probably is unnecessary for mast cell
development.23
Regulation of basophil development by RUNX1
RUNX1, a key regulator of early hematopoiesis, also regulates
basophil development.9 Runx1 is transcribed from both a distal
promoter (P1) and a proximal promoter (P2) to produce transcripts
with distinct 5ʹ UTRs.47 Inmice deﬁcient in RUNX1 derived from the
P1 promoter, the number of GPs, BMCPs, and mast cells do not
change, but the numbers of BaPs and basophils are markedly
reduced, suggesting a requirement for RUNX1 in the generation of
basophils (Fig. 2B).9 The molecular mechanism of RUNX1 regula-
tion of basophil lineage development has not been clariﬁed.
Functions of IRF8 in basophil and mast cell development
IRF8 is expressed in myeloid and B cell lineages and is required
for the development of dendritic cells, monocytes, and eosinophils,
while it suppresses neutrophil development.48e52 Recently, we
reported that IRF8 is important also for basophil and mast cell
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BMPs, BaPs, MCPs, and basophils are severely diminished, while
bone marrow GPs, spleen BMCPs, tissue MCPs, and mast cells are as
abundant as those in wild-type mice (Fig. 2B).17,51 An analysis of
IRF8 protein expression using IRF8-GFP chimeric knock-in mice53
revealed that IRF8 is expressed in GPs but not in downstream
progeny of the basophil and mast cell lineages.17 Interestingly,
transplantation and in vitro culture experiments revealed that IRF8
functions in GPs to promote the development of not only basophils
but also mast cells.
A computational analysis of transcription factor binding motifs
based on transcriptomedataofwild-typeGPs and IRF8-deﬁcientGPs
predicted that the GATA family transcription factors are likely to
contribute to basophil and mast cell development downstream of
IRF8. Although Gata1 and Gata2mRNA expression levels are down-
regulated in Irf8/GPs, GATA1 protein is undetectable even inwild-
type GPs, while GATA2 protein expression is readily detected in
wild-type GPs and is markedly decreased in Irf8/ GPs (Fig. 3).
Moreover, it was revealed that when transduced into Irf8/
progenitors, only GATA2 is able to restore differentiation into baso-
phils and partially into mast cells. These results clariﬁed that IRF8
induces GATA2 expression in GPs, facilitating basophil andmast cell
development. Whether IRF8 directly induces Gata2 remains un-
known; however, we speculate that it may be indirect andmediated
by other transcription factor(s), because the induction of GATA2
expression by forced expression of IRF8 requires substantial time.
Why tissue MCPs and mast cells are as abundant in Irf8/ mice
as in the wild type, despite the fact that Irf8/ mice lack bone
marrow MCPs and that IRF8 does promote mast cell development
in vitro, has not been clariﬁed. We speculate that both survival and
proliferation of tissue MCPs and mast cells are enhanced, allowing
them to reach normal levels, because of the extremely high blood
IgE levels in Irf8/ mice.54 Such effects of IgE are known,55 and
tissue MCPs (but not bone marrow MCPs) and mast cells express
FcεRI.
Analysis of genome-wide transcription factor binding regions
in mast cells
For a comprehensive understanding of how transcription fac-
tors regulate cell differentiation, a genome-wide analysis using
ChIP followed by high-throughput DNA sequencing (ChIP-seq) is a
powerful approach. G€ottgens et al. compared the SCF-dependent
hematopoietic stem and progenitor cell (HSPC)-like cell line HPC7
with bone marrow-derived mast cells (BMMCs) and found that
many transcription factors involved in development and function
of HSPCs are expressed similarly in HPC7s and BMMCs.56 These
transcription factors include E2A/TCF3, ETS-related gene (ERG),
Friend leukemia integration 1 (FLI1), GATA2, LIM domain only 2
(LMO2), Meis homeobox 1 (MEIS1), PU.1/SPI1, RUNX1, and stem cell
leukemia (SCL): hereinafter referred to as “common transcription
factors.” Indeed, HSPCs and mast cells share characteristics such as
the capacity for SCF-dependent self-renewal. However, these two
cell types have substantially different morphologies and functions.
Therefore, the authors performed ChIP-seq analyses of the com-
mon transcription factors in HPC7s and BMMCs.56 The results
showed that multiple transcription factors tend to bind contigu-
ously to speciﬁc regions, but the genomic locations of these binding
regions, as well as the gene expression patterns, differ substantially
between HPC7s and BMMCs. An analysis of DNA motifs in the
transcription factor binding sites revealed that the binding motifs
of FBJ osteosarcoma oncogene (FOS) and MITF are signiﬁcantly
more overrepresented in BMMCs than HPC7s.56 The authors
then performed ChIP-seq analyses of FOS and MITF to demonstratethat these transcription factors, which are expressed more highly
in mast cells than in HSPCs, indeed bind to the sites mentioned
above in BMMCs. These results showed that the difference in
binding sites of “common transcription factors” between HPC7s
and mast cells may be caused by binding of cell-speciﬁc tran-
scription factors. Interestingly, knockdown or knockout of the
common transcription factor GATA2 in BMMCs resulted in down-
regulation of mast cell-speciﬁc genes such as Kit andMitf.56,57 Thus,
common transcription factors and cell type-speciﬁc transcription
factors are likely to cooperate to establish cell type-speciﬁc gene
expression proﬁles.56
Recently, large active enhancer regions termed super-enhancers
have been shown to be critical for the establishment of cell type-
speciﬁc gene expression patterns.58,59 In super-enhancers, there
are region termed “hotspots” to which multiple transcription fac-
tors strongly bind.58,60 We speculate that the regions discovered by
G€ottgens et al., to which multiple transcription factors bind
contiguously, include those in super-enhancers. Future analyses
focusing on the role of super-enhancers in the development of
basophils and mast cells may elucidate the mechanism by which
the identities of similar but distinct cell types, basophils and mast
cells, are established.
Discussion
As described above, the pathways and key transcription factors
for the development of basophils and mast cells have been eluci-
dated (Fig. 3). Speciﬁcally, GATA2 expression by IRF8 in GPs, and
the induction of C/EBPa and MITF expression by the STAT5-GATA2
cascade in bipotential progenitors (pre-BMPs and possibly BMCPs)
and downstream cells appear to be essential for promoting baso-
phil and mast cell development. Because IRF8 is no longer
expressed at the bipotential progenitor and downstream cell
stages, it is conceivable that STAT5 takes over from IRF8 to induce
GATA2 expression. Moreover, the mutually exclusive expression of
C/EBPa and MITF underlies the basophil versus mast cell fate. In
addition, IKAROS downregulates C/EBPa expression to suppress
differentiation into basophils, presumably after the pre-BMP and
BMCP stages.
Nevertheless, target genes of these transcription factors are not
yet known on a genome scale. Therefore, ChIP-seq analyses of
transcription factors and various histone modiﬁcations will be key
for future studies. In addition, though various progenitors have
been identiﬁed, their exact relationships and whether they are
homogenous populations are still obscure. To resolve these issues,
transcriptome analyses using single-cell RNA-seq and detailed cell
tracking experiments are required. Indeed, in a recent study, single
cell RNA-seq analysis of early myeloid progenitors (lineage
markers Sca1 c-Kitþ cells) indicated that these cells might be
already transcriptionally primed toward a single cell lineage such
as basophils.61 Moreover, the analyses of several transcription
factor-deﬁcient mice would have to be re-conducted based on the
current knowledge of the basophil and mast cell developmental
pathways. Lastly, whether any changes in these developmental
pathways occur with infections and allergies is still obscure. We
expect that a deeper understanding of the differentiation of baso-
phils and mast cells will contribute to the development of new
therapies that control the production of basophils and mast cells.
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